|
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
Jon Salmanton-García
,
Francesco Marchesi
,
Francesca Farina
,
Barbora Weinbergerová
,
Federico Itri
et al.
Article dans une revue
hal-04908727
v1
|
|
Frontal Intermittent Rhythmic Delta Activity Is a Useful Diagnostic Tool of Neurotoxicity After CAR T-Cell Infusion.
Sophie Huby
,
Philippe Gelisse
,
Jean‐jacques Tudesq
,
Pierre Labauge
,
Claire Duflos
et al.
Article dans une revue
hal-04071772
v1
|
|
Arginine metabolism regulates human erythroid differentiation through hypusination of eIF5A
Pedro Gonzalez-Menendez
,
Ira Phadke
,
Meagan Olive
,
Axel Joly
,
Julien Papoin
et al.
Article dans une revue
hal-03986199
v1
|
|
Anti‐PD ‐1 therapy can possibly reverse CAR T cells exhaustion in DLBCL
Sylvain Lamure
,
Charles Herbaux
Article dans une revue
hal-04918596
v1
|
|
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey
Jaap van Doesum
,
Jon Salmanton-García
,
Francesco Marchesi
,
Roberta Di Blasi
,
Iker Falces-Romero
et al.
Article dans une revue
hal-04911244
v1
|
|
Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis
Thomas Hueso
,
Anne-Sophie Godron
,
Emilie Lanoy
,
Jérôme Pacanowski
,
Laura Levi
et al.
Article dans une revue
hal-03642648
v1
|
|
Outcome of COVID-19 in Patients with Mantle Cell Lymphoma—Report from the European MCL Registry
Marie Kristin Tilch
,
Carlo Visco
,
Sandra Bašić Kinda
,
Olivier Hermine
,
Milena Kohn
et al.
Article dans une revue
hal-03673380
v1
|
|
COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP
Alessandro Busca
,
Jon Salmanton-García
,
Paolo Corradini
,
Francesco Marchesi
,
Alba Cabirta
et al.
Article dans une revue
hal-03645421
v1
|
|
Outcome of infection with omicron <scp>SARS‐CoV</scp> ‐2 variant in patients with hematological malignancies: An <scp>EPICOVIDEHA</scp> survey report
Ola Blennow
,
Jon Salmanton-García
,
Piotr Nowak
,
Federico Itri
,
Jaap van Doesum
et al.
Article dans une revue
hal-03791162
v1
|
|
Parkinsonian Patients Requiring Proteasome Inhibitors for Multiple Myeloma: Exceptional Circumstances Call for Extra Caution
Pierre Rocanières
,
Sylvain Lamure
,
Christian Geny
,
Dominique Hillaire-Buys
,
Jean-Luc Faillie
et al.
Article dans une revue
hal-04142920
v1
|
|
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)
Maria Stefania Infante
,
Jon Salmanton-García
,
Ana Fernández-Cruz
,
Francesco Marchesi
,
Ozren Jaksic
et al.
Article dans une revue
hal-04427149
v1
|
|
COVID-19 in adult acute myeloid leukemia patients: a long-term followup study from the European Hematology Association survey (EPICOVIDEHA)
Francesco Marchesi
,
Jon Salmanton-García
,
Ziad Emarah
,
Klára Piukovics
,
Marcio Nucci
et al.
Article dans une revue
hal-03791177
v1
|
|
COVID-19 and Hairy-Cell Leukemia: An EPICOVIDEHA Survey
Sylvain Lamure
,
Jon Salmanton-García
,
Elena Robin Marieton
,
Ozren Jaksic
,
Milena Kohn
et al.
Article dans une revue
hal-03690034
v1
|
|
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from EPICOVIDEHA survey
Livio Pagano
,
Jon Salmanton-García
,
Francesco Marchesi
,
Ola Blennow
,
Maria Gomes da Silva
et al.
Article dans une revue
hal-03791153
v1
|
|
Characteristics of SARS-CoV-2 infection in lymphoma/chronic lymphocytic leukemia patients during the Omicron outbreak
Milena Kohn
,
Tamim Alsuliman
,
Sylvain Lamure
,
Morgane Cheminant
,
Jéremy Delage
et al.
Article dans une revue
hal-03791160
v1
|
|
COVID-19 in vaccinated adult patients with hematological malignancies. Preliminary results from EPICOVIDEHA
Livio Pagano
,
Jon Salmanton-García
,
Francesco Marchesi
,
Alberto López-García
,
Sylvain Lamure
et al.
Article dans une revue
hal-03791235
v1
|
|
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
Livio Pagano
,
Jon Salmanton-García
,
Francesco Marchesi
,
Alessandro Busca
,
Paolo Corradini
et al.
Article dans une revue
hal-03642030
v1
|
|
Clinical and Product Features Associated with Outcome of DLBCL Patients to CD19-Targeted CAR T-Cell Therapy
Sylvain Lamure
,
François van Laethem
,
Delphine de Verbizier
,
Claire Lozano
,
Eve Gehlkopf
et al.
Article dans une revue
hal-03327590
v1
|
|
Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy
Rémy Duléry
,
Sylvain Lamure
,
Marc Delord
,
Roberta Di Blasi
,
Adrien Chauchet
et al.
Article dans une revue
hal-03401859
v1
|
|
Nouvelle AMM : duvelisib – LLC et lymphome folliculaire en rechute ou réfractaire
Léa Fornero
,
Sylvain Lamure
Article dans une revue
hal-03791143
v1
|
|
Immunomonitoring du rituximab appliqué aux maladies auto-immunes : une aide pour la pratique clinique ?
Megane Giraud
,
Pascal Cathébras
,
X. Roblin
,
Damien Thibaudin
,
Sylvain Lamure
et al.
Article dans une revue
hal-03203418
v1
|
|
COVID-19 and CAR-T cells: current challenges and future directions-a report from the EPICOVIDEHA survey by EHA-IDWP
Alessandro Busca
,
Jon Salmanton-García
,
Paolo Corradini
,
Francesco Marchesi
,
Alba Cabirta
et al.
Article dans une revue
hal-03430350
v1
|
|
Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization database
Radjiv Goulabchand
,
Nicolas Malafaye
,
William Jacot
,
Philine Witkowski Durand Viel
,
Jacques Morel
et al.
Article dans une revue
hal-03622565
v1
|
|
Immunomonitoring du rituximab appliqué aux maladies auto-immunes : une aide pour la pratique clinique ?
M. Giraud
,
P. Cathébras
,
X. Roblin
,
D. Thibaudin
,
S. Lamure
et al.
Article dans une revue
hal-04872979
v1
|
|
Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study
Sylvain Lamure
,
Rémy Duléry
,
Roberta Di Blasi
,
Adrien Chauchet
,
Cécile Laureana
et al.
Article dans une revue
hal-03203358
v1
|
|
The Plasmatic Aldosterone and C-Reactive Protein Levels, and the Severity of Covid-19: The Dyhor-19 Study
Orianne Villard
,
David Morquin
,
Nicolas Molinari
,
Isabelle Raingeard
,
Nicolas Nagot
et al.
Article dans une revue
hal-02906692
v1
|
|
A Retrospective Comparison of DLI and gDLI for Post-Transplant Treatment
Sylvain Lamure
,
Franciane Paul
,
Anne-Laure Gagez
,
Jérémy Delage
,
Laure Vincent
et al.
Article dans une revue
hal-03203259
v1
|
|
Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B‐cell lymphoma, a clinico‐pathological series of 25 cases
Guillaume Aussedat
,
Alexandra Traverse‐glehen
,
Aspasia Stamatoullas
,
Thierry Molina
,
Violaine Safar
et al.
Article dans une revue
hal-02872482
v1
|
|
Description of neurotoxicity in a series of patients treated with CAR T-cell therapy
Catherine Belin
,
Perrine Devic
,
Xavier Ayrignac
,
Amélie dos Santos
,
Adrien Paix
et al.
Article dans une revue
hal-03203401
v1
|
|
Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells
Claire Gourzones
,
Céline Bellanger
,
Sylvain Lamure
,
Ouissem Karmous Gadacha
,
Elvira Garcia de Paco
et al.
Article dans une revue
hal-02870153
v1
|
|
Association of Occupational Pesticide Exposure With Immunochemotherapy Response and Survival Among Patients With Diffuse Large B-Cell Lymphoma
Sylvain Lamure
,
Camille Carles
,
Quam Aquereburu
,
Philippe Quittet
,
Emmanuelle Tchernonog
et al.
Article dans une revue
hal-02863305
v1
|
|
Injections de lymphocytes du donneur (DLI) : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
John de Vos
,
Etienne Baudoux
,
Jacques-Olivier Bay
,
Boris Calmels
,
Audrey Cras
et al.
Article dans une revue
hal-02650987
v1
|
|
Injections de lymphocytes du donneur (DLI) : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
John de Vos
,
Etienne Baudoux
,
Jacques-Olivier Bay
,
Boris Calmels
,
Audrey Cras
et al.
Bulletin du Cancer, 2019, 106 (1), pp.S35-S39
Article dans une revue
hal-02055937
v1
|
|
Infusion of in vivo expanded cord blood lymphocytes: A new strategy to control residual disease?
S. Lamure
,
J. Delage
,
L. Vincent
,
N. Fegueux
,
L. Zhao-Yang
et al.
Article dans une revue
hal-03122708
v1
|
|
Transfusion thérapeutique de granulocytes : cinétique et aspects organisationnels autour d’un cas clinique
Sylvain Lamure
,
P. Latry
,
T. Kanouni
,
Y. Hicheri
,
L Vincent
et al.
Article dans une revue
hal-03203379
v1
|